-+ 0.00%
-+ 0.00%
-+ 0.00%

CONTINEUM THERAPEUTICS, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $22 FROM $25

Reuters·09/15/2026 10:56:52

Please log in to view news